Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy

Lancet

Volumn 362, Issue 9385, 2003, Pages 697-703

  Askari, Arman T ^a   Unzek, Samuel ^a   Popovic, Zoran B ^a   Goldman, Corey K ^a   Forudi, Farhad ^a   Kiedrowski, Matthew ^a   Rovner, Aleksandr ^a   Ellis, Stephen G ^a   Thomas, James D ^a   DiCorleto, Paul E ^a   Topol, Eric J ^a   Penn, Marc S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CARDIOMYOPATHY; CONTROLLED STUDY; DOPPLER FLOWMETRY; DOWN REGULATION; ECHOCARDIOGRAPHY; FIBROBLAST; HEART; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE MASS; ISCHEMIC HEART DISEASE; ISOGRAFT; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; STEM CELL; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; UPREGULATION;

EID: 0041327804     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14232-8     Document Type: Article

References (30)

1. Topol E.J. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet. 357:2001;1905-1914.
2. Robbins M.A., O'Connell J.B. Economic impact of heart failure. Rose E.A., Stevenson L.W. Management of end-stage heart disease. 1998;3-13 Lippincott-Raven, Philadelphia.
3. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 81:1990;1161-1172.
4. Penn M.S., Francis G.S., Ellis S.G., Young J.B., McCarthy P.M., Topol E.J. Autologous cell therapy for the treatment of damaged myocardium. Prog Cardiovasc Dis. 45:2002;21-32.
5. Taylor D.A., Atkins B.Z., Hungspreugs P., et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 4:1998;929-933.
6. Etzion S., Battler A., Barbash I.M., et al. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol. 33:2001;1321-1330.
7. Yoo K.J., Li R.K., Weisel R.D., et al. Smooth muscle cells transplantation is better than heart cells transplantation for improvement of heart function in dilated cardiomyopathy. Yonsei Med J. 43:2002;296-303.
8. Sakai T., Li R.K., Weisel R.D., et al. Fetal cell transplantation: a comparison of three cell types. J Thorac Cardiovasc Surg. 118:1999;715-724.
9. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature. 410:2001;701-705.
10. Tomita S., Mickle D.A., Weisel R.D., et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg. 123:2002;1132-1140.
11. Jackson K.A., Majka S.M., Wang H., et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 107:2001;1395-1402.
12. Quaini F., Urbanek K., Beltrami A.P., et al. Chimerism of the transplanted heart. N Engl J Med. 346:2002;5-15.
13. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 7:2001;430-436.
14. Orlic D., Kajstura J., Chimenti S., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 98:2001;10344-10349.
15. Levesque J.P., Hendy J., Takamatsu Y., Simmons P.J., Bendall L.J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest. 111:2003;187-196.
16. Petit I., Szyper-Kravitz M., Nagler A., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol. 3:2002;687-694.
17. Doitsidou M., Reichman-Fried M., Stebler J., et al. Guidance of primordial germ cell migration by the chemokine SDF-1. Cell. 111:2002;647-659.
18. Yamaguchi J., Kusano K.F., Masuo O., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 107:2003;1322-1328.
19. Hattori K., Heissig B., Tashiro K., et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood. 97:2001;3354-3360.
20. Heissig B., Hattori K., Dias S., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 109:2002;625-637.
21. Askari A., Brennan M.L., Zhou X., et al. Myeloperoxidase and plasminogen activator inhibitor-1 play a central role in ventricular remodeling after myocardial infarction. J Exp Med. 197:2003;615-624.
22. Collins K.A., Korcarz C.E., Shroff S.G., et al. Accuracy of echocardiographic estimates of left ventricular mass in mice. Am J Physiol Heart Circ Physiol. 280:2001;H1954-H1962.
23. Wright D.E., Cheshier S.H., Wagers A.J., Randall T.D., Christensen J.L., Weissman I.L. Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. Blood. 97:2001;2278-2285.
24. Yong K., Fahey A., Reeve L., et al. Cord blood progenitor cells have greater transendothelial migratory activity and increased responses to SDF-1 and MIP-3beta compared with mobilized adult progenitor cells. Br J Haematol. 107:1999;441-449.
25. Liesveld J.L., Rosell K., Panoskaltsis N., Belanger T., Harbol A., Abboud C.N. Response of human CD34+ cells to CXC, CC, and CX3C chemokines: implications for cell migration and activation. J Hematother Stem Cell Res. 10:2001;643-655.
26. Greenberg N.L., Firstenberg M.S., Castro P.L., et al. Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility. Circulation. 105:2002;99-105.
27. Firstenberg M.S., Greenberg N.L., Smedira N.G., Castro P., Thomas J.D., Garcia M.J. The effects of acute coronary occlusion on noninvasive echocardiographically derived systolic and diastolic myocardial strain rates. Curr Surg. 57:2000;466-472.
28. Nagasawa T., Hirota S., Tachibana K., et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 382:1996;635-638.
29. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 393:1998;595-599.
30. Behfar A., Zingman L.V., Hodgson D.M., et al. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J. 16:2002;1558-1566.